Vascular Abnormalities in Raynaud's Phenomenon

Raynaud M . On asphyxia and symmetrical gangrene of the extremities, 1862, and new research on the nature and treatment of local asphyxia of the extremities, 1872. Barlow T , trans. In: selected monographs, vol 121. London, New Syndenham Society, 1988.

Goodfield MJD , Hume A , Rowell NR . The acute affects of cigarette smoking on cutaneous blood flow in smoking and non-smoking subjects with and without Raynaud's phenomenon. Br J Rheumatol 1990; 29: 89–91.

Lafferty K , De Trafford JC , Potter C , Tobert VC , Cotton LT . Reflex vascular responses in the finger to contralateral thermal stimuli during the normal menstrual cycle: a hormonal basis to Raynaud's phenomenon? Clin Sci 1985; 68: 10–15.

Maricq HR , Weinrich MC , Keil JE , Le Roy CE . Prevalence of Raynaud's phenomenon in the general population. J Chronic Dis 1986; 39: 423–27.

Fitzgerald O , Hess EV , O'Connor GT , Spencer-Green G . Prospective study of the evolution of Raynaud's phenomenon. Am JMed 1988; 84: 718–26.

Belch JJF . Raynaud's Phenomenon: it's relevance to scleroderma (Comment). Ann Rheum Dis 1991; 50: 839–45.

Belch JJF . An update on the Phenomenon, syndrome and disease of Maurice Raynaud (Editorial). Brit J Rheum 1990; 24 (3): 162–65.

Kallenberg CGM , Waida AA , Hoet MH Development of connective tissue disease presenting with Raynaud's phenomenon: a 6 year follow-up with emphasis on predictive value of autoantibodies as detected by immunoblotting. Ann Rheum Dis 1988; 4: 634–41.

Taylor W . The hand-arm vibration syndrome, secondary Raynaud's phenomenon of occupational origin. Proc R College Physicians, Edinburgh 1989; 19: 7–14.

Belch JJF . Raynaud's phenomenon. Curr Opin Rheumatol 1990; 2: 937–41.

Freedman RR , Sabharwal SC , Desai N , Wenig P , Mayes M . Increased a-adrenergic responsiveness in idiopathic Raynaud's disease. Arthritis Rheum 1989; 32 (1): 61–65.

Coffman JD , Cohen RA . a2-adrenergic and 5-HT receptor hypersensitivity in Raynaud's phenomenon. J Vasc Med Biol 1990; 2 (3): 100–106.

Keenan EJ , Porter JM . a2-adrenergic receptors in patients with Raynaud's syndrome. Surgery 1983; 94: 204–209.

Olsen N , Hansen SW . Vasomotor functions of skin microcirculation in vasospastic Raynaud's phenomena. Acta Physiol Scand 1991; 143 (suppl. 603): 101–107.

Bunker CB , Terenghi G , Springhall DR , Polak JM , Dowd PM . Deficiency of calcitonin gene-related peptide in Raynaud's phenomenon. Lancet 1990; 336: 1530–33.

Furchgott RF , Zawadski JV . The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373–76.

Moncada S , Higgs EA . The L-arginin e-nitric oxide pathway. N Engl J Med 1993; 329: 2002–2012.

Khan F , Litchfield SJ , McLaren M , Veale DJ , Littleford RC , Belch JJF: Oral L-arginine supplementation and cutaneous vascular responses in patients with primary Raynaud's phenomenon. Arthritis Rheum 1997; 40 (2): 352–57.

La Civita L , Rossi M , Vagheggini G , Storina FAA , Credidio L , Pasero G , Giusti C Ferri C: Microvascular involvement in systemic sclerosis: laser Doppler evaluation of reactivity to acetylcholine and sodium nitroprusside by iontophoresis. Ann Rheum Dis 1998; S7: 52–55.

Bedarida GV , Kim D , Blaschke TF , Hoffman BB . Venodilation in Raynaud's disease. Lancet 1993; 342: 1451–54.

Leppert J , Ringqvist A , Ahlner J , Myrdal U , Sorensen S , Ringqvist I . Cold exposure increases cyclic guanosine monophosphate in healthy women but not in women with Raynaud's phenomenon. J Int Med 1995; 237: 493–98.

Khan F , Coffman JD: Enhanced cholinergic cutaneous vasodilation in Raynaud's phenomenon. Circulation 1992; 89: 1183–88.

Anderson ME , Hollis S , Moore T , Jayson MIV , Herrick AL: Non-invasive assessment of vascular reactivity in forearm skin of patients with primary Raynaud's phenomenon and systemic sclerosis. Br J Rheumatol 1996; 35: 1281–88.

Ringqvist A , Jonason T , Leppert J , Ringqvist I . Non-invasive investigation of endothelium-dependent dilation of the brachial artery in women with primary Raynaud's phenomenon. Clin Sci 1998; 94: 239–43.

Rustin MHA , Bull HA , Machin SJ , Koro O , Dowd PM . Serum from patients with Raynaud's phenomenon inhibits prostaglandin release. J Invest Dermatol 1987; 89: 555–59.

Raynaud's phenomenon; Grand round. Lancet 1995; 346: 283–290.

Zamora MR , O'Brien RF , Rutherford RB , Weil JV . Serum endothelin-1 concentration and cold provocation in primary Raynaud's phenomenon. Lancet 1990; 336: 1144–47.

Belch JJF , Zoma A , Richards I , Forbes CD , Sturrock RD . Vascular damage and factor VIII related antigen in the rheumatic disease. Rheumatol Int 1987; 7: 107–111.

Lau CS , McLaren M , Mackay IR , Belch JJF . Baseline plasma fibrinolysis and its correlation with clinical manifestations in patients with Raynaud's Phenomenon. Ann Rheum Dis 1993; 52: 443–448.

Belch JJF , McLaren M , Anderson J , Lowe GDO , Sturrock RD , Capell HA , Forbes CD . Increased prostacyclin metabolites and decreased red cell deformability in patients with systemic sclerosis and Raynaud's syndrome. Prostagland Leuko Med 1985; 17: 1–9.

Lau CS , McLaren M , Belch JJF . Factor VII von Willebrand factor antigen levels correlate with symptom severity in patients with Raynaud's Phenomenon. Br JRheum 1991; 30 (6): 433–36.

Belch JJF , Maple C . Raynaud's Phenomenon. In: Connective T issue Disease. Belch JJF , Zurier R (Eds), Chapman and Hall, London 1995: 131–150.

Lau CS . Haemostatic abnormalities in Raynaud's Phenomenon and the potential for treatment with manipulation of the arachidonic acid pathway. MD Thesis awarded with Honours, University of Dundee 1992.

Lau CS , McLaren M , Saniabadi A , Belch JJF . Increased whole blood platelet aggregation in patients with Raynaud's Phenomenon with and without systemic sclerosis. Scand J Rheumatol 1993; 22: 97–101.

Lau CS , Bridges A , Muir A , Scott N , Bancroft A , Belch JJF . Further evidence of increased polymorphonuclear cell activity in patients with Raynaud's phenomenon. Br J Rheumatol 1992; 31: 375–80.

Maricq HR . Raynaud's Phenomenon and microvascular abnormalities in scleroderma (systemic sclerosis), in Systemic S clerosis: Scleroderma (eds Jayson MIV , Black CB ). London: J Wiley & Sons: 151–166.

ter Borg EJ , Piersma-Wichers G , Smit AL Serial nailfold capillary microscopy in primary Raynaud's Phenomenon and Scleroderma Semin Arthrit Rheum 1994; Vol 24: 40–47.

Bukhari M , Herrick AL , Moore T , Manning J , Jayson MI . Increased nailfold capillary dimensions in primary Raynaud's phenomenon and systemic sclerosis. Br J Rheumatol 1996; 35: 1127–31.

Belch JJF . Raynaud's phenomenon. Cardiovasc Res 1997; 33: 25–33.

Belch JJF , Ho M . Pharmacotherapy of Raynaud's phenomenon. Drugs 1996; 52 (5): 682–95.

Belch JJF , Land D , Park RHR , McKillop IH , McKenzie JF . Decreased oesophageal blood flow in patients with Raynaud's Phenomenon. Brit J Rheumatol 1988; 27: 426–30.

Miller D , Waters DD , Warnica W , Szlachcic J , Kreeft J , Theroux P . Is variant angina the coronary manifestation of a generalised vasospastic disorder. NEngl JMed 1981; 304 (13): 763–66.